Intelligent Bio Solutions, Inc. (INBS)
1.52
-0.01
(-0.65%)
USD |
NASDAQ |
Oct 12, 12:00
Intelligent Bio Solutions Enterprise Value : 2.052M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.052M |
| October 08, 2026 | 2.169M |
| October 07, 2026 | 2.227M |
| October 06, 2026 | 2.198M |
| October 05, 2026 | 2.459M |
| October 02, 2026 | 2.430M |
| October 01, 2026 | 2.430M |
| September 30, 2026 | 2.459M |
| September 29, 2026 | 2.343M |
| September 28, 2026 | 2.401M |
| September 25, 2026 | 2.546M |
| September 24, 2026 | 2.576M |
| September 23, 2026 | 2.750M |
| September 22, 2026 | 2.837M |
| September 21, 2026 | 2.866M |
| September 18, 2026 | 3.273M |
| September 17, 2026 | 3.418M |
| September 16, 2026 | 3.331M |
| September 15, 2026 | 3.563M |
| September 14, 2026 | 3.622M |
| September 11, 2026 | 3.796M |
| September 10, 2026 | 3.970M |
| September 09, 2026 | 4.115M |
| September 08, 2026 | 3.854M |
| September 04, 2026 | 4.086M |
| Date | Value |
|---|---|
| September 03, 2026 | 4.290M |
| September 02, 2026 | 4.784M |
| September 01, 2026 | 4.668M |
| August 31, 2026 | 4.580M |
| August 28, 2026 | 4.464M |
| August 27, 2026 | 4.203M |
| August 26, 2026 | 4.174M |
| August 25, 2026 | 4.464M |
| August 24, 2026 | 4.871M |
| August 21, 2026 | 4.90M |
| August 20, 2026 | 5.307M |
| August 19, 2026 | 5.365M |
| August 18, 2026 | 6.963M |
| August 17, 2026 | 7.399M |
| August 14, 2026 | 5.655M |
| August 13, 2026 | 6.324M |
| August 12, 2026 | 4.987M |
| August 11, 2026 | 3.563M |
| August 10, 2026 | 3.302M |
| August 07, 2026 | 3.36M |
| August 06, 2026 | 3.389M |
| August 05, 2026 | 2.808M |
| August 04, 2026 | 2.866M |
| August 03, 2026 | 2.895M |
| July 31, 2026 | 2.866M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanara MedTech, Inc. | 355.51M |
| Anteris Technologies Global Corp. | 405.69M |
| 20/20 Biolabs, Inc. | 2.159M |
| Quest Diagnostics, Inc. | 31.55B |
| Labcorp Holdings, Inc. | 31.89B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.917M |
| Revenue (Quarterly) | 1.146M |
| Total Expenses (Quarterly) | 5.054M |
| EPS Diluted (Quarterly) | -1.345 |
| Gross Profit Margin (Quarterly) | 21.68% |
| Profit Margin (Quarterly) | -341.9% |
| Earnings Yield | -621.5% |
| Normalized Earnings Yield | -605.84 |